Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
inTUne: Oral Testosterone Undecanoate in Hypogonadal Men
NCT02722278Phase 3Completed
- Sponsor
- Clarus Therapeutics
- Start
- Mar 2016
- Primary completion
- Nov 2016
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of testosterone undecanoate in Hypogonadism, sponsored by Clarus Therapeutics. Started Mar 2016; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02722278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722278.